The Supreme Court has issued its opinion in Alice v. CLS Bank case. In the case Alice v. CLS Bank: Alice Corp. owned several patents covering a computer system that helps with closing financial transactions by avoiding settlement risk (the risk that comes with any financial transaction if one party cannot uphold its end of the bargain)….
Bayramoglu Law Offices has recently successfully appealed a case to Patent Trial and Appeal Board (PTAB). The case application number is 11/963,796. The Appeal number is 2011-008945. The application was rejected by the Examiner. PTAB reversed the Examiner on all grounds therefore allowing the patent grant for the application. Considering the reversal rate of Examiners…
The USPTO is extending a popular program that allows patent applicants to submit minor amendments for consideration after final rejection. Launched in May 2013, the USPTO’s After Final Consideration Pilot is designed to reduce patent application pendency and help applicants avoid the time and cost associated with Requests for Continued Examination (RCEs) after final rejection. To take…
The Quick Path Information Disclosure Statement (QPIDS) pilot program is part of the USPTO’s on-going efforts towards compact prosecution and pendency reduction. In particular, the QPIDS pilot program eliminates the requirement for processing of a request for continued examination (RCE) with an information disclosure statement (IDS) filed after payment of the issue fee in order…
USPTO After Final Consideration Pilot 2.0 Like AFCP, AFCP 2.0 authorizes additional time for examiners to search and/or consider responses after final rejection. Under AFCP 2.0, examiners will also use the additional time to schedule and conduct an interview to discuss the results of their search and/or consideration with you, if your response does not place…
Dr. Bayramoglu was interviewed by China’s CCTV on 29 October 2011. The video can be viewed at the link below: http://english.cntv.cn/program/rediscoveringchina/20111029/101634.shtml
The US Supreme Court, in a nearly unanimous ruling (Scalia joined the majority for most of the decision), has held that a piece of DNA that occurs naturally is not eligible for patenting. This means that any sequences that are normally present in the human genome—or that of any other organism—cannot be the subject of…
Do you know that USPTO implemented a new program where an inventor or applicant can qualify for a “micro entity” wherein certain office fees are further reduced? If you want to know more about it please contact us either at 702-724-2628 or send us an email with your question: in@bayramoglu-legal.com. Do you know that you can make…